{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:51:01Z","timestamp":1788501061667,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report here that the potent HNF4\u03b1 agonist N-trans-caffeoyltyramine (NCT) promotes weight loss by inducing an increase in mitochondrial mass and function, including fatty acid oxidation. Previously, we found in a short term trial in obese mice that NCT promoted reversal of hepatic steatosis through a mechanism involving the stimulation of lipophagy by dihydroceramides. NCT led to increased dihydroceramide levels by inhibiting dihydroceramide conversion to ceramides. Here, we were able to administer NCT orally, permitting longer term administration. Mice fed NCT mixed with high fat diet exhibited decreased weight. Examination of RNA-seq data revealed an increase in PPARGC1A, a central regulator of mitochondrial biogenesis. In addition to the decreased hepatic steatosis that we found previously, mice fed a high fat diet containing NCT mice weighed substantially less than control mice fed high fat diet alone. They had increased mitochondrial mass, exhibited increased fatty acid oxidation, and had an increased level of NAD. Markers of liver inflammation such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF\u03b1), which are important in the progression of non-alcoholic fatty liver disease to non-alcoholic steatohepatitis were decreased by NCT. There was no evidence of any toxicity from NCT consumption. These results indicate that HNF4\u03b1 is an important regulator of mitochondrial mass and function and support that use of HNF4\u03b1 to treat disorders of fatty acid excess, potentially including obesity, NAFLD, and NASH.<\/jats:p>","DOI":"10.1038\/s41419-022-04521-5","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T09:03:01Z","timestamp":1643274181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Long-term oral administration of an HNF4\u03b1 agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function"],"prefix":"10.1038","volume":"13","author":[{"given":"Vimal","family":"Veeriah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7336-2526","authenticated-orcid":false,"given":"Fred","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"4521_CR1","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.3748\/wjg.v25.i30.4074","volume":"25","author":"MM Yeh","year":"2019","unstructured":"Yeh MM, Bosch DE, Daoud SS. Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases. World J Gastroenterol. 2019;25:4074\u201391.","journal-title":"World J Gastroenterol"},{"key":"4521_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1097-2765(02)00605-6","volume":"10","author":"F Sladek","year":"2002","unstructured":"Sladek F. Desperately seeking\u2026something. Mol Cell. 2002;10:219\u201321.","journal-title":"Mol Cell"},{"key":"4521_CR3","doi-asserted-by":"publisher","first-page":"37973","DOI":"10.1074\/jbc.C200420200","volume":"277","author":"S Dhe-Paganon","year":"2002","unstructured":"Dhe-Paganon S, Duda K, Iwamoto M, Chi YI, Shoelson SE. Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J Biol Chem. 2002;277:37973\u20136.","journal-title":"J Biol Chem"},{"key":"4521_CR4","doi-asserted-by":"publisher","first-page":"e5609","DOI":"10.1371\/journal.pone.0005609","volume":"4","author":"X Yuan","year":"2009","unstructured":"Yuan X, Ta TC, Lin M, Evans JR, Dong Y, Bolotin E, et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS ONE. 2009;4:e5609.","journal-title":"PLoS ONE"},{"key":"4521_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.chembiol.2012.05.014","volume":"19","author":"A Kiselyuk","year":"2012","unstructured":"Kiselyuk A, Lee SH, Farber-Katz S, Zhang M, Athavankar S, Cohen T, et al. HNF4alpha antagonists discovered by a high-throughput screen for modulators of the human insulin promoter. Chem Biol. 2012;19:806\u201318.","journal-title":"Chem Biol"},{"key":"4521_CR6","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1021\/cb4000986","volume":"8","author":"SH Lee","year":"2013","unstructured":"Lee SH, Athavankar S, Cohen T, Piran R, Kiselyuk A, Levine F. Identification of alverine and benfluorex as HNF4alpha activators. ACS Chem Biol. 2013;8:1730\u20136.","journal-title":"ACS Chem Biol"},{"key":"4521_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-03862-x","volume":"12","author":"SH Lee","year":"2021","unstructured":"Lee SH, Veeriah V, Levine F. Liver fat storage is controlled by HNF4\u00e0 through induction of lipophagy and is reversed by a potent HNF4\u00e0 agonist. Cell Death Dis. 2021;12:1\u201318.","journal-title":"Cell Death Dis"},{"key":"4521_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.tem.2012.06.005","volume":"23","author":"LR Stein","year":"2012","unstructured":"Stein LR, Imai S. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab. 2012;23:420\u20138.","journal-title":"Trends Endocrinol Metab"},{"key":"4521_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0003-2697(89)90149-8","volume":"179","author":"A Bergel","year":"1989","unstructured":"Bergel A, Souppe J, Comtat M. Enzymatic amplification for spectrophotometric and electrochemical assays of NAD+ and NADH. Anal Biochem. 1989;179:382\u20138.","journal-title":"Anal Biochem"},{"key":"4521_CR10","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1194\/jlr.M092379","volume":"60","author":"SC Kwong","year":"2019","unstructured":"Kwong SC, Jamil AHA, Rhodes A, Taib NA, Chung I. Metabolic role of fatty acid binding protein 7 in mediating triple-negative breast cancer cell death via PPAR-alpha signaling. J lipid Res. 2019;60:1807\u201317.","journal-title":"J lipid Res"},{"key":"4521_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphys.2017.00460","volume":"8","author":"AKS Camara","year":"2017","unstructured":"Camara AKS, Zhou Y, Wen PC, Tajkhorshid E, Kwok WM. Mitochondrial VDAC1: a key gatekeeper as potential therapeutic target. Front Physiol. 2017;8:460.","journal-title":"Front Physiol"},{"key":"4521_CR12","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1113\/jphysiol.2012.230185","volume":"590","author":"S Larsen","year":"2012","unstructured":"Larsen S, Nielsen J, Hansen CN, Nielsen LB, Wibrand F, Stride N, et al. Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol. 2012;590:3349\u201360.","journal-title":"J Physiol"},{"key":"4521_CR13","doi-asserted-by":"publisher","first-page":"13382","DOI":"10.1021\/acs.chemrev.7b00257","volume":"117","author":"D Alvarez-Paggi","year":"2017","unstructured":"Alvarez-Paggi D, Hannibal L, Castro MA, Oviedo-Rouco S, Demicheli V, Tortora V, et al. Multifunctional cytochrome c: learning new tricks from an old dog. Chem Rev. 2017;117:13382\u2013460.","journal-title":"Chem Rev"},{"key":"4521_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15:349\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4521_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/JME-19-0207","volume":"64","author":"T Xiao","year":"2020","unstructured":"Xiao T, Liang X, Liu H, Zhang F, Meng W, Hu F. Mitochondrial stress protein HSP60 regulates ER stress-induced hepatic lipogenesis. J Mol Endocrinol. 2020;64:67\u201375.","journal-title":"J Mol Endocrinol"},{"key":"4521_CR16","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1210\/jc.2010-2129","volume":"96","author":"P Pettinelli","year":"2011","unstructured":"Pettinelli P, Videla LA. Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction. J Clin Endocrinol Metab. 2011;96:1424\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"4521_CR17","doi-asserted-by":"publisher","first-page":"e11707","DOI":"10.1371\/journal.pone.0011707","volume":"5","author":"X Kong","year":"2010","unstructured":"Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y, et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE. 2010;5:e11707.","journal-title":"PLoS ONE"},{"key":"4521_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.advms.2015.09.003","volume":"61","author":"M Watroba","year":"2016","unstructured":"Watroba M, Szukiewicz D. The role of sirtuins in aging and age-related diseases. Adv Med Sci. 2016;61:52\u201362.","journal-title":"Adv Med Sci"},{"key":"4521_CR19","doi-asserted-by":"publisher","first-page":"16456","DOI":"10.1074\/jbc.M501485200","volume":"280","author":"S Nemoto","year":"2005","unstructured":"Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem. 2005;280:16456\u201360.","journal-title":"J Biol Chem"},{"key":"4521_CR20","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1478-3231.2007.01497.x","volume":"27","author":"XQ Deng","year":"2007","unstructured":"Deng XQ, Chen LL, Li NX. The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats. Liver Int. 2007;27:708\u201315.","journal-title":"Liver Int"},{"key":"4521_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.15280\/jlm.2014.4.2.80","volume":"4","author":"EH Cho","year":"2014","unstructured":"Cho EH. SIRT3 as a regulator of non-alcoholic fatty liver disease. J Lifestyle Med. 2014;4:80\u20135.","journal-title":"J Lifestyle Med"},{"key":"4521_CR22","doi-asserted-by":"publisher","first-page":"107755","DOI":"10.1016\/j.neuropharm.2019.107755","volume":"160","author":"P Lu","year":"2019","unstructured":"Lu P, Hogan-Cann AD, Kamboj A, Roy Chowdhury SK, Aghanoori MR, Fernyhough P, et al. Poly(ADP-ribose) polymerase-1 inhibits mitochondrial respiration by suppressing PGC-1alpha activity in neurons. Neuropharmacology 2019;160:107755.","journal-title":"Neuropharmacology"},{"key":"4521_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","volume":"15","author":"JN Sharma","year":"2007","unstructured":"Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 2007;15:252\u20139.","journal-title":"Inflammopharmacology"},{"key":"4521_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3389\/fphys.2020.00767","volume":"11","author":"RP Cunningham","year":"2020","unstructured":"Cunningham RP, Sheldon RD, Rector RS. The emerging role of hepatocellular eNOS in Non-alcoholic fatty liver disease development. Front Physiol. 2020;11:767.","journal-title":"Front Physiol"},{"key":"4521_CR25","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bbamcr.2010.09.019","volume":"1813","author":"RC Scarpulla","year":"2011","unstructured":"Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta. 2011;1813:1269\u201378.","journal-title":"Biochim Biophys Acta"},{"key":"4521_CR26","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1073\/pnas.0730870100","volume":"100","author":"J Rhee","year":"2003","unstructured":"Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, Gonzalez FJ, et al. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci USA. 2003;100:4012\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4521_CR27","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1126\/science.1089769","volume":"303","author":"DT Odom","year":"2004","unstructured":"Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004;303:1378\u201381.","journal-title":"Science"},{"key":"4521_CR28","doi-asserted-by":"publisher","first-page":"15363","DOI":"10.1073\/pnas.2002250117","volume":"117","author":"JD Chavez","year":"2020","unstructured":"Chavez JD, Tang X, Campbell MD, Reyes G, Kramer PA, Stuppard R, et al. Mitochondrial protein interaction landscape of SS-31. Proc Natl Acad Sci USA. 2020;117:15363\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4521_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev-pharmtox-010715-103155","volume":"56","author":"RM Whitaker","year":"2016","unstructured":"Whitaker RM, Corum D, Beeson CC, Schnellmann RG. Mitochondrial biogenesis as a pharmacological target: a new approach to acute and chronic diseases. Annu Rev Pharm Toxicol. 2016;56:229\u201349.","journal-title":"Annu Rev Pharm Toxicol"},{"key":"4521_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cmet.2016.09.017","volume":"25","author":"TES Kauppila","year":"2017","unstructured":"Kauppila TES, Kauppila JHK, Larsson NG. Mammalian mitochondria and aging: an update. Cell Metab. 2017;25:57\u201371.","journal-title":"Cell Metab"},{"key":"4521_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-10-68","volume":"10","author":"M Niehof","year":"2009","unstructured":"Niehof M, Borlak J. Expression of HNF4alpha in the human and rat choroid plexus: implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier. BMC Mol Biol. 2009;10:68.","journal-title":"BMC Mol Biol"},{"key":"4521_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bbrc.2015.03.153","volume":"460","author":"J Janikiewicz","year":"2015","unstructured":"Janikiewicz J, Hanzelka K, Kozinski K, Kolczynska K, Dobrzyn A. Islet beta-cell failure in type 2 diabetes-Within the network of toxic lipids. Biochem Biophys Res Commun. 2015;460:491\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"4521_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1872-034X.2012.01031.x","volume":"43","author":"P Loria","year":"2013","unstructured":"Loria P, Lonardo A, Anania F. Liver and diabetes. A vicious circle. Hepatol Res. 2013;43:51\u201364.","journal-title":"Hepatol Res"},{"key":"4521_CR34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41419-021-03862-x","volume":"12","author":"SH Lee","year":"2021","unstructured":"Lee SH, Veeriah V, Levine F. Liver fat storage is controlled by HNF4alpha through induction of lipophagy and is reversed by a potent HNF4alpha agonist. Cell Death Dis. 2021;12:603.","journal-title":"Cell Death Dis"},{"key":"4521_CR35","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/nprot.2013.055","volume":"8","author":"A Mehlem","year":"2013","unstructured":"Mehlem A, Hagberg CE, Muhl L, Eriksson U, Falkevall A. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc. 2013;8:1149\u201354.","journal-title":"Nat Protoc"},{"key":"4521_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3748\/wjg.v23.i2.204","volume":"23","author":"T Kostrzewski","year":"2017","unstructured":"Kostrzewski T, Cornforth T, Snow SA, Ouro-Gnao L, Rowe C, Large EM, et al. Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. World J Gastroenterol. 2017;23:204\u201315.","journal-title":"World J Gastroenterol"},{"key":"4521_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/cpmo.21","volume":"7","author":"PM Quiros","year":"2017","unstructured":"Quiros PM, Goyal A, Jha P, Auwerx J. Analysis of mtDNA\/nDNA ratio in mice. BCurr Protoc Mouse Biol 2017;7:47\u201354.","journal-title":"BCurr Protoc Mouse Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04521-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:01:43Z","timestamp":1669302103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04521-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["4521"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04521-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No human subjects were used.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}